학술논문

Phase I study of cabazitaxel plus cisplatin in patients with advanced solid tumors: study to evaluate the impact of cytochrome P450 3A inhibitors (aprepitant, ketoconazole) or inducers (rifampin) on the pharmacokinetics of cabazitaxel.
Document Type
Academic Journal
Source
Cancer Chemotherapy & Pharmacology (CANCER CHEMOTHER PHARMACOL), Dec2014; 74(6): 1113-1124. (12p)
Subject
Language
English
ISSN
0344-5704